FDA-Drug2020-12-23Class II
Azacitidine for Injection 100 mg/vial For Subcutaneous and Intravenous Use Only Single-Dose Vial Manufactured by Shilpa Medicare Limited Jadcherla -509301 INDIA Distributed by: Cipla USA, Inc. 10 Independence Blvd, Suite 300 Warren, NJ 07059 NDC 69097-805-40
CIPLA
Hazard
cGMP deviations: Vials may not be sealed correctly affecting sterility.
Sold states
USA Nationwide
Affected count
2151 vials
Manufactured in
10 Independence Blvd, N/A, Warren, NJ, United States
Products
Azacitidine for Injection 100 mg/vial For Subcutaneous and Intravenous Use Only Single-Dose Vial Manufactured by Shilpa Medicare Limited Jadcherla -509301 INDIA Distributed by: Cipla USA, Inc. 10 Independence Blvd, Suite 300 Warren, NJ 07059 NDC 69097-805-40
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0165-2021Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief